Gynecologic Cancer,Other Cancers ARIEL4: Rucaparib vs Standard Chemotherapy for Relapsed Ovarian Cancer With BRCA1/2 Mutation May 08, 2023
Gynecologic Cancer,Other Cancers Mirvetuximab Soravtansine PK Analysis in FRα-Positive Cancer Patients May 08, 2023
Gynecologic Cancer,Other Cancers Atezolizumab and Chemotherapy for Advanced Ovarian Cancer May 08, 2023
Gynecologic Cancer,Other Cancers Defining Benefit of Rucaparib Maintenance in Newly Diagnosed Ovarian Cancer: ATHENA-MONO Phase III Study May 08, 2023
Breast Cancer,Other Cancers Exploring the Safety and Efficacy of Adjuvant Giredestrant: The lidERA Breast Cancer Trial May 08, 2023
Gynecologic Cancer,Other Cancers Maintenance Selinexor vs Placebo in Endometrial Cancer: SIENDO Study May 08, 2023
Gynecologic Cancer,Other Cancers Rucaparib Maintenance Benefit in High-Grade Ovarian Carcinoma: ARIEL3 Exceptional Responders May 08, 2023
